Gene: PAPLN
Official Full Name: papilin, proteoglycan like sulfated glycoproteinprovided by HGNC
Gene Summary: Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in extracellular matrix organization. Predicted to be located in basement membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23890 | PAPLN Knockout cell line (HeLa) | Human | PAPLN | 1:3~1:6 | Negative | Online Inquiry |
KO23891 | PAPLN Knockout cell line (HCT 116) | Human | PAPLN | 1:2~1:4 | Negative | Online Inquiry |
KO23892 | PAPLN Knockout cell line (HEK293) | Human | PAPLN | 1:3~1:6 | Negative | Online Inquiry |
KO23893 | PAPLN Knockout cell line (A549) | Human | PAPLN | 1:3~1:4 | Negative | Online Inquiry |
PAPLN Gene Knockout Cell Lines are specially engineered cell lines developed to facilitate in-depth exploration of the biological functions and mechanisms associated with the PAPLN (Papilin) gene. Gene knockout techniques utilize CRISPR/Cas9 technology to create targeted deletions within the gene sequence, effectively silencing its expression. This allows researchers to investigate the resultant phenotypic changes that occur in cellular behavior, adhesion properties, migration, and signal transduction pathways, thus providing insight into PAPLN's role in various physiological and pathological processes.
The primary function of PAPLN is to encode a glycoprotein involved in the extracellular matrix, which is crucial for cellular communication and tissue organization. By knocking out PAPLN, researchers can elucidate its contribution to developmental biology and disease states such as cancer and fibrosis. The precise genetic modification ensures that the cell lines are reliable tools for studying gene function, drug response, and developing therapeutic strategies.
In the realm of research and clinical applications, PAPLN Gene Knockout Cell Lines provide a significant advantage over traditional models. They enable high-throughput screening and functional assays, allowing researchers to rapidly evaluate the effects of pharmacological compounds or genetic interventions in a controlled environment. Compared to other cell line models, these knockout lines offer specificity and reproducibility, making them indispensable for researchers focused on gene function.
Researchers and clinicians benefit from utilizing PAPLN Gene Knockout Cell Lines because they enhance the understanding of gene interactions and disease pathology, potentially leading to breakthroughs in targeted therapies. Our commitment to quality and innovation is reflected in our rigorous validation processes, ensuring that our products meet the highest standards of scientific rigor and reliability. As experts in gene editing technologies, we are dedicated to providing researchers with the tools they need to advance their work in molecular and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.